Cannabis Toxicity in Pets: Rising Risks as CBD Products Hit Shelves

Cannabis Toxicity in Pets Rising as CBD Products Reach Store Shelves

Pet poison calls about marijuana and CBD products climbed sharply as legalization spread — and veterinarians now sell and recommend cannabis-derived products themselves. A 2018 review by Ahna Brutlag of Pet Poison Helpline and the University of Minnesota, published in Veterinary Clinics of North America, maps both sides of this trend: real therapeutic potential in epilepsy care, and real toxicity risks when animals ingest THC-containing products.

How the Endocannabinoid System Explains Both Benefit and Toxicity

Dogs and cats possess the same endocannabinoid system as humans: receptors (CB1 and CB2), endogenous signaling molecules like anandamide, and enzymes that build and break these compounds down. Brutlag and co-author Holly Hommerding explain that CB1 receptors cluster densely in the cerebellum, cerebral cortex, and brainstem — which is precisely why THC intoxication produces the signs it does in pets.

THC acts as a partial agonist at CB1 receptors. Dogs have more CB1 receptors in their brains than many other species, making them especially sensitive to THC’s psychoactive effects. CBD, in contrast, has low affinity for CB1 receptors and does not produce the “high” — it works indirectly, including through modulation of anandamide breakdown and activity at non-cannabinoid targets such as TRPV1 receptors and serotonin pathways. This mechanistic split matters clinically: pure CBD carries a wide safety margin, while THC ingestion can cause genuine poisoning.

What Toxicology Data Show About Cannabis Exposure in Dogs and Cats

The Pet Poison Helpline review describes the typical poisoning picture. Dogs — who ingest marijuana plant material, edibles, or concentrates directly — most often show ataxia (wobbling), urine dribbling, dilated pupils, slowed heart rate, vocalization, and disorientation. Symptoms usually begin within 30 minutes to a few hours of oral exposure and can persist for one to three days because THC is lipophilic and stored in fat, prolonging its release. Less common but documented: tremors, seizures, and, in a small number of severe cases, death.

Brutlag flags synthetic cannabinoids — illegal compounds sprayed onto plant material and sold under names like “K2” or “Spice” — as especially concerning. These designer drugs bind CB1 receptors far more powerfully than THC, and veterinary case reports have linked them to severe neurological signs and fatalities in dogs. Chocolate-laced edibles compound the risk, adding theobromine toxicity on top of cannabinoid exposure.

CBD products present a different picture. Per the review, CBD itself appears well tolerated in pets, but quality control is inconsistent: some over-the-counter products contain far more THC than labeled, which converts a “safe” supplement into a poisoning risk. Treatment in poisoning cases is largely supportive — decontamination with activated charcoal, lipid emulsion therapy in severe THC cases to sequester the fat-soluble drug, anti-nausea medication, and nursing care.

Measuring CBD and THC in Epileptic Dogs: A Validated Laboratory Method

Evidence for therapeutic use is also advancing. A 2017 study from Italy’s Istituto Superiore di Sanità, led by Marco Carlo Rotolo with veterinary colleagues at Clinica Veterinaria Roma Sud, published in Current Pharmaceutical Biotechnology, developed and validated a gas chromatography–mass spectrometry (GC-MS) assay to quantify both THC and CBD in dog plasma. They tested it on eight dogs receiving oral medical cannabis (a formulation called Bediol) for epilepsy treatment.

The numbers show the method is robust: analytical recovery of 80.6% for THC and 81.7% for CBD, precision values consistently under 13% across intra- and inter-assay runs, and less than 10% interference from the plasma itself. The team then tracked THC and CBD kinetics in two dogs at multiple time points after dosing — demonstrating, for the first time with a validated tool, that clinicians can precisely monitor cannabinoid blood levels during therapy.

This matters more than it might seem. As Rotolo’s group notes, studies on clinical cannabinoid use in veterinary medicine remain limited, and reliable measurement methods for animal biological matrices were previously missing. Without knowing actual blood concentrations, dosing cannabis for canine epilepsy is guesswork — and guesswork risks both treatment failure and THC overexposure.

What This Means for Pet Owners and Veterinarians

Practical takeaways follow directly from the two studies. First, transparency with your veterinarian is non-negotiable: owners sometimes withhold cannabis exposure out of embarrassment, delaying diagnosis. Second, only use products with third-party certificates of analysis confirming CBD content and near-zero THC — mislabeled products are a documented hazard. Third, never administer human medical cannabis preparations to pets without veterinary guidance, since THC: CBD ratios appropriate for people can intoxicate a dog.

For therapeutic use — epilepsy, anxiety, osteoarthritis pain — the field is moving toward evidence-based protocols built on pharmacokinetic data like Rotolo’s. For a broader look at the evidence, see our coverage of the systematic review of CBD benefits and risks in pets, evidence across species in CBD for dogs, cats, and horses, and long-term dosing data in CBD pharmacokinetics research. If you’re considering CBD for a specific condition, our articles on CBD for canine arthritis and CBD for dogs with cancer, pain, and anxiety review condition-specific findings.

Frequently Asked Questions

Is CBD toxic to dogs and cats?

CBD itself has a wide safety margin and appears well tolerated, but products contaminated with THC or mislabeled can cause toxicity — a 2018 toxicology review emphasizes that product quality, not CBD, drives most adverse events.

What are the signs of marijuana toxicity in pets?

Wobbling gait, dribbling urine, dilated pupils, disorientation, and vocalization are most common in dogs; signs typically begin within hours and can last one to three days because THC is stored in body fat.

Is medical cannabis being used for canine epilepsy?

Yes. Italian veterinarians treated eight epileptic dogs with oral medical cannabis (Bediol), and researchers validated a lab method to measure THC and CBD blood levels — a step toward standardized dosing, though clinical studies remain limited.

Can synthetic cannabinoids harm pets?

Synthetics like “K2” and “Spice” bind brain receptors much more strongly than THC and have been linked to severe neurological signs and deaths in dogs, making them far more dangerous than natural marijuana.

Conclusion

Two papers from 2017 and 2018 frame the current state of veterinary cannabis: Brutlag’s toxicology review shows rising pet exposure alongside legalization, and Rotolo’s validated GC-MS assay demonstrates that precise monitoring of cannabinoid therapy in dogs is now achievable. The compound CBD shows genuine therapeutic promise, particularly for epilepsy, but THC contamination and dosing uncertainty remain real hazards. Veterinary supervision, verified products, and honest communication remain the safest path forward.

Sources:
https://pubmed.ncbi.nlm.nih.gov/30342565/
https://pubmed.ncbi.nlm.nih.gov/29173160/